home / stock / evok / evok short
Short Information | Evoke Pharma Inc. (NASDAQ:EVOK)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 48,379 |
Total Actual Volume | 289,478 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 1 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 2,419 |
Average Short Percentage | 24.19% |
Is there a EVOK Short Squeeze or Breakout about to happen?
See the EVOK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-30-2023 | $1.29 | $1.2975 | $1.3084 | $1.28 | 5,076 | 2,023 | 39.85% |
11-29-2023 | $1.2367 | $1.2611 | $1.285 | $1.2367 | 7,882 | 93 | 1.18% |
11-28-2023 | $1.27 | $1.21 | $1.29 | $1.21 | 5,997 | 197 | 3.28% |
11-27-2023 | $1.25 | $1.3 | $1.3815 | $1.2 | 124,307 | 8,846 | 7.12% |
11-24-2023 | $1.25 | $1.25 | $1.33 | $1.22 | 11,181 | 2,258 | 20.19% |
11-22-2023 | $1.25 | $1.2545 | $1.2545 | $1.18 | 3,457 | 499 | 14.43% |
11-21-2023 | $1.2 | $1.21 | $1.21 | $1.2 | 734 | 118 | 16.08% |
11-20-2023 | $1.29 | $1.245 | $1.29 | $1.24 | 5,348 | 1,996 | 37.32% |
11-17-2023 | $1.305 | $1.29 | $1.32 | $1.2229 | 5,564 | 631 | 11.34% |
11-16-2023 | $1.23 | $1.27 | $1.35 | $1.18 | 11,408 | 2,123 | 18.61% |
11-15-2023 | $1.3 | $1.27 | $1.3791 | $1.26 | 4,727 | 514 | 10.87% |
11-14-2023 | $1.3 | $1.34 | $1.49 | $1.2 | 30,619 | 6,139 | 20.05% |
11-13-2023 | $1.22 | $1.25 | $1.2999 | $1.2 | 19,797 | 5,478 | 27.67% |
11-10-2023 | $1.15 | $1.25 | $1.25 | $1.15 | 8,625 | 1,893 | 21.95% |
11-09-2023 | $1.15 | $1.28 | $1.33 | $1.15 | 26,677 | 6,582 | 24.67% |
11-08-2023 | $1.16 | $1.16 | $1.17 | $1.1275 | 1,225 | 600 | 48.98% |
11-07-2023 | $1.15 | $1.15 | $1.185 | $1.1182 | 2,720 | 415 | 15.26% |
11-06-2023 | $1.175 | $1.15 | $1.175 | $1.15 | 1,800 | 393 | 21.83% |
11-03-2023 | $1.1132 | $1.19 | $1.1958 | $1.1132 | 6,151 | 5,101 | 82.93% |
11-02-2023 | $1.22 | $1.2 | $1.23 | $1.1705 | 6,183 | 2,480 | 40.11% |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Evoke Pharma CEO Dave Gonyer joined Steve Darling from Proactive to share news the company has achieved a significant milestone with the listing of its recently issued U.S. patent related to GIMOTI in the U.S. Food and Drug Administration's publication, commonly known as t...
SOLANA BEACH, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily...
SOLANA BEACH, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that its recently...